世界のガンドチニブ市場予測 2023年-2029年

◆英語タイトル:Global Gandotinib Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23JU1210)◆商品コード:LP23JU1210
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年5月
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のガンドチニブ市場」は、過去の販売実績から2022年の世界のガンドチニブの総販売量を検討し、2023年から2029年の予測されるガンドチニブの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のガンドチニブの市場規模を掲載し、XXX百万米ドル規模の世界のガンドチニブ市場の詳細な分析を提供します。本インサイトレポートは、世界のガンドチニブ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のガンドチニブ市場における各社の独自のポジションをより深く理解するために、ガンドチニブ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のガンドチニブ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ガンドチニブの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。ガンドチニブの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ガンドチニブのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ガンドチニブの世界主要メーカーとしては、BioVision、 Selleck Chemicals、 BOC Sciences、 TargetMol、 MyBiosource、 Adooq Bioscience、 Toronto Research Chemicals、 AbMole、 Taiclone、 Axon Medchem、 CSNpharm、 AA BLOCKS、 MedKoo、 Wuhan Sun-Shine Bio-Technology、 Biosynth Carbosynth、 Biorbytなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のガンドチニブ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではガンドチニブ市場をセグメンテーションし、種類別 (純度98%以下、純度98%~99%、純度99%以上)、用途別 (研究、医療)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:純度98%以下、純度98%~99%、純度99%以上

・用途別区分:研究、医療

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のガンドチニブ市場の10年間の市場状況・展望は?
・世界および地域別に見たガンドチニブ市場成長の要因は何か?
・ガンドチニブの市場機会はエンドマーケットの規模によってどのように変化するのか?
・ガンドチニブのタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:ガンドチニブの年間販売量2018-2029、地域別現状・将来分析
・ガンドチニブの種類別セグメント:純度98%以下、純度98%~99%、純度99%以上
・ガンドチニブの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・ガンドチニブの用途別セグメント:研究、医療
・ガンドチニブの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のガンドチニブ市場
・企業別のグローバルガンドチニブ市場データ:2018-2023年の年間販売量、市場シェア
・企業別のガンドチニブの年間売上:2018-2023年の売上、市場シェア
・企業別のガンドチニブ販売価格
・主要企業のガンドチニブ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ガンドチニブの地域別レビュー
・地域別のガンドチニブ市場規模2018-2023:年間販売量、売上
・主要国別のガンドチニブ市場規模2018-2023:年間販売量、売上
・南北アメリカのガンドチニブ販売の成長
・アジア太平洋のガンドチニブ販売の成長
・ヨーロッパのガンドチニブ販売の成長
・中東・アフリカのガンドチニブ販売の成長

南北アメリカ市場
・南北アメリカの国別のガンドチニブ販売量、売上(2018-2023)
・南北アメリカのガンドチニブの種類別販売量
・南北アメリカのガンドチニブの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のガンドチニブ販売量、売上(2018-2023)
・アジア太平洋のガンドチニブの種類別販売量
・アジア太平洋のガンドチニブの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のガンドチニブ販売量、売上(2018-2023)
・ヨーロッパのガンドチニブの種類別販売量
・ヨーロッパのガンドチニブの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のガンドチニブ販売量、売上(2018-2023)
・中東・アフリカのガンドチニブの種類別販売量
・中東・アフリカのガンドチニブの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ガンドチニブの製造コスト構造分析
・ガンドチニブの製造プロセス分析
・ガンドチニブの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・ガンドチニブの主要なグローバル販売業者
・ガンドチニブの主要なグローバル顧客

地域別のガンドチニブ市場予測レビュー
・地域別のガンドチニブ市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ガンドチニブの種類別市場規模予測
・ガンドチニブの用途別市場規模予測

主要企業分析
BioVision、 Selleck Chemicals、 BOC Sciences、 TargetMol、 MyBiosource、 Adooq Bioscience、 Toronto Research Chemicals、 AbMole、 Taiclone、 Axon Medchem、 CSNpharm、 AA BLOCKS、 MedKoo、 Wuhan Sun-Shine Bio-Technology、 Biosynth Carbosynth、 Biorbyt
・企業情報
・ガンドチニブ製品
・ガンドチニブ販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

Gandotinib is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
LPI (LP Information)’ newest research report, the “Gandotinib Industry Forecast” looks at past sales and reviews total world Gandotinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Gandotinib sales for 2023 through 2029. With Gandotinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gandotinib industry.
This Insight Report provides a comprehensive analysis of the global Gandotinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gandotinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gandotinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gandotinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gandotinib.
The global Gandotinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gandotinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gandotinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gandotinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gandotinib players cover BioVision, Selleck Chemicals, BOC Sciences, TargetMol, MyBiosource, Adooq Bioscience, Toronto Research Chemicals, AbMole and Taiclone, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gandotinib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Medical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BioVision
Selleck Chemicals
BOC Sciences
TargetMol
MyBiosource
Adooq Bioscience
Toronto Research Chemicals
AbMole
Taiclone
Axon Medchem
CSNpharm
AA BLOCKS
MedKoo
Wuhan Sun-Shine Bio-Technology
Biosynth Carbosynth
Biorbyt
Key Questions Addressed in this Report
What is the 10-year outlook for the global Gandotinib market?
What factors are driving Gandotinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gandotinib market opportunities vary by end market size?
How does Gandotinib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gandotinib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gandotinib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gandotinib by Country/Region, 2018, 2022 & 2029
2.2 Gandotinib Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Gandotinib Sales by Type
2.3.1 Global Gandotinib Sales Market Share by Type (2018-2023)
2.3.2 Global Gandotinib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gandotinib Sale Price by Type (2018-2023)
2.4 Gandotinib Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Gandotinib Sales by Application
2.5.1 Global Gandotinib Sale Market Share by Application (2018-2023)
2.5.2 Global Gandotinib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gandotinib Sale Price by Application (2018-2023)
3 Global Gandotinib by Company
3.1 Global Gandotinib Breakdown Data by Company
3.1.1 Global Gandotinib Annual Sales by Company (2018-2023)
3.1.2 Global Gandotinib Sales Market Share by Company (2018-2023)
3.2 Global Gandotinib Annual Revenue by Company (2018-2023)
3.2.1 Global Gandotinib Revenue by Company (2018-2023)
3.2.2 Global Gandotinib Revenue Market Share by Company (2018-2023)
3.3 Global Gandotinib Sale Price by Company
3.4 Key Manufacturers Gandotinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gandotinib Product Location Distribution
3.4.2 Players Gandotinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gandotinib by Geographic Region
4.1 World Historic Gandotinib Market Size by Geographic Region (2018-2023)
4.1.1 Global Gandotinib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gandotinib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gandotinib Market Size by Country/Region (2018-2023)
4.2.1 Global Gandotinib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gandotinib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gandotinib Sales Growth
4.4 APAC Gandotinib Sales Growth
4.5 Europe Gandotinib Sales Growth
4.6 Middle East & Africa Gandotinib Sales Growth
5 Americas
5.1 Americas Gandotinib Sales by Country
5.1.1 Americas Gandotinib Sales by Country (2018-2023)
5.1.2 Americas Gandotinib Revenue by Country (2018-2023)
5.2 Americas Gandotinib Sales by Type
5.3 Americas Gandotinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gandotinib Sales by Region
6.1.1 APAC Gandotinib Sales by Region (2018-2023)
6.1.2 APAC Gandotinib Revenue by Region (2018-2023)
6.2 APAC Gandotinib Sales by Type
6.3 APAC Gandotinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gandotinib by Country
7.1.1 Europe Gandotinib Sales by Country (2018-2023)
7.1.2 Europe Gandotinib Revenue by Country (2018-2023)
7.2 Europe Gandotinib Sales by Type
7.3 Europe Gandotinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gandotinib by Country
8.1.1 Middle East & Africa Gandotinib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gandotinib Revenue by Country (2018-2023)
8.2 Middle East & Africa Gandotinib Sales by Type
8.3 Middle East & Africa Gandotinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gandotinib
10.3 Manufacturing Process Analysis of Gandotinib
10.4 Industry Chain Structure of Gandotinib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gandotinib Distributors
11.3 Gandotinib Customer
12 World Forecast Review for Gandotinib by Geographic Region
12.1 Global Gandotinib Market Size Forecast by Region
12.1.1 Global Gandotinib Forecast by Region (2024-2029)
12.1.2 Global Gandotinib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gandotinib Forecast by Type
12.7 Global Gandotinib Forecast by Application
13 Key Players Analysis
13.1 BioVision
13.1.1 BioVision Company Information
13.1.2 BioVision Gandotinib Product Portfolios and Specifications
13.1.3 BioVision Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BioVision Main Business Overview
13.1.5 BioVision Latest Developments
13.2 Selleck Chemicals
13.2.1 Selleck Chemicals Company Information
13.2.2 Selleck Chemicals Gandotinib Product Portfolios and Specifications
13.2.3 Selleck Chemicals Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Selleck Chemicals Main Business Overview
13.2.5 Selleck Chemicals Latest Developments
13.3 BOC Sciences
13.3.1 BOC Sciences Company Information
13.3.2 BOC Sciences Gandotinib Product Portfolios and Specifications
13.3.3 BOC Sciences Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BOC Sciences Main Business Overview
13.3.5 BOC Sciences Latest Developments
13.4 TargetMol
13.4.1 TargetMol Company Information
13.4.2 TargetMol Gandotinib Product Portfolios and Specifications
13.4.3 TargetMol Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 TargetMol Main Business Overview
13.4.5 TargetMol Latest Developments
13.5 MyBiosource
13.5.1 MyBiosource Company Information
13.5.2 MyBiosource Gandotinib Product Portfolios and Specifications
13.5.3 MyBiosource Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MyBiosource Main Business Overview
13.5.5 MyBiosource Latest Developments
13.6 Adooq Bioscience
13.6.1 Adooq Bioscience Company Information
13.6.2 Adooq Bioscience Gandotinib Product Portfolios and Specifications
13.6.3 Adooq Bioscience Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Adooq Bioscience Main Business Overview
13.6.5 Adooq Bioscience Latest Developments
13.7 Toronto Research Chemicals
13.7.1 Toronto Research Chemicals Company Information
13.7.2 Toronto Research Chemicals Gandotinib Product Portfolios and Specifications
13.7.3 Toronto Research Chemicals Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Toronto Research Chemicals Main Business Overview
13.7.5 Toronto Research Chemicals Latest Developments
13.8 AbMole
13.8.1 AbMole Company Information
13.8.2 AbMole Gandotinib Product Portfolios and Specifications
13.8.3 AbMole Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AbMole Main Business Overview
13.8.5 AbMole Latest Developments
13.9 Taiclone
13.9.1 Taiclone Company Information
13.9.2 Taiclone Gandotinib Product Portfolios and Specifications
13.9.3 Taiclone Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Taiclone Main Business Overview
13.9.5 Taiclone Latest Developments
13.10 Axon Medchem
13.10.1 Axon Medchem Company Information
13.10.2 Axon Medchem Gandotinib Product Portfolios and Specifications
13.10.3 Axon Medchem Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Axon Medchem Main Business Overview
13.10.5 Axon Medchem Latest Developments
13.11 CSNpharm
13.11.1 CSNpharm Company Information
13.11.2 CSNpharm Gandotinib Product Portfolios and Specifications
13.11.3 CSNpharm Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 CSNpharm Main Business Overview
13.11.5 CSNpharm Latest Developments
13.12 AA BLOCKS
13.12.1 AA BLOCKS Company Information
13.12.2 AA BLOCKS Gandotinib Product Portfolios and Specifications
13.12.3 AA BLOCKS Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 AA BLOCKS Main Business Overview
13.12.5 AA BLOCKS Latest Developments
13.13 MedKoo
13.13.1 MedKoo Company Information
13.13.2 MedKoo Gandotinib Product Portfolios and Specifications
13.13.3 MedKoo Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 MedKoo Main Business Overview
13.13.5 MedKoo Latest Developments
13.14 Wuhan Sun-Shine Bio-Technology
13.14.1 Wuhan Sun-Shine Bio-Technology Company Information
13.14.2 Wuhan Sun-Shine Bio-Technology Gandotinib Product Portfolios and Specifications
13.14.3 Wuhan Sun-Shine Bio-Technology Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Wuhan Sun-Shine Bio-Technology Main Business Overview
13.14.5 Wuhan Sun-Shine Bio-Technology Latest Developments
13.15 Biosynth Carbosynth
13.15.1 Biosynth Carbosynth Company Information
13.15.2 Biosynth Carbosynth Gandotinib Product Portfolios and Specifications
13.15.3 Biosynth Carbosynth Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Biosynth Carbosynth Main Business Overview
13.15.5 Biosynth Carbosynth Latest Developments
13.16 Biorbyt
13.16.1 Biorbyt Company Information
13.16.2 Biorbyt Gandotinib Product Portfolios and Specifications
13.16.3 Biorbyt Gandotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Biorbyt Main Business Overview
13.16.5 Biorbyt Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Gandotinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gandotinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Gandotinib Sales by Type (2018-2023) & (Kg)
Table 7. Global Gandotinib Sales Market Share by Type (2018-2023)
Table 8. Global Gandotinib Revenue by Type (2018-2023) & ($ million)
Table 9. Global Gandotinib Revenue Market Share by Type (2018-2023)
Table 10. Global Gandotinib Sale Price by Type (2018-2023) & (K USD/Kg)
Table 11. Global Gandotinib Sales by Application (2018-2023) & (Kg)
Table 12. Global Gandotinib Sales Market Share by Application (2018-2023)
Table 13. Global Gandotinib Revenue by Application (2018-2023)
Table 14. Global Gandotinib Revenue Market Share by Application (2018-2023)
Table 15. Global Gandotinib Sale Price by Application (2018-2023) & (K USD/Kg)
Table 16. Global Gandotinib Sales by Company (2018-2023) & (Kg)
Table 17. Global Gandotinib Sales Market Share by Company (2018-2023)
Table 18. Global Gandotinib Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Gandotinib Revenue Market Share by Company (2018-2023)
Table 20. Global Gandotinib Sale Price by Company (2018-2023) & (K USD/Kg)
Table 21. Key Manufacturers Gandotinib Producing Area Distribution and Sales Area
Table 22. Players Gandotinib Products Offered
Table 23. Gandotinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Gandotinib Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Gandotinib Sales Market Share Geographic Region (2018-2023)
Table 28. Global Gandotinib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Gandotinib Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Gandotinib Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Gandotinib Sales Market Share by Country/Region (2018-2023)
Table 32. Global Gandotinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Gandotinib Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Gandotinib Sales by Country (2018-2023) & (Kg)
Table 35. Americas Gandotinib Sales Market Share by Country (2018-2023)
Table 36. Americas Gandotinib Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Gandotinib Revenue Market Share by Country (2018-2023)
Table 38. Americas Gandotinib Sales by Type (2018-2023) & (Kg)
Table 39. Americas Gandotinib Sales by Application (2018-2023) & (Kg)
Table 40. APAC Gandotinib Sales by Region (2018-2023) & (Kg)
Table 41. APAC Gandotinib Sales Market Share by Region (2018-2023)
Table 42. APAC Gandotinib Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Gandotinib Revenue Market Share by Region (2018-2023)
Table 44. APAC Gandotinib Sales by Type (2018-2023) & (Kg)
Table 45. APAC Gandotinib Sales by Application (2018-2023) & (Kg)
Table 46. Europe Gandotinib Sales by Country (2018-2023) & (Kg)
Table 47. Europe Gandotinib Sales Market Share by Country (2018-2023)
Table 48. Europe Gandotinib Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Gandotinib Revenue Market Share by Country (2018-2023)
Table 50. Europe Gandotinib Sales by Type (2018-2023) & (Kg)
Table 51. Europe Gandotinib Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Gandotinib Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Gandotinib Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Gandotinib Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Gandotinib Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Gandotinib Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Gandotinib Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Gandotinib
Table 59. Key Market Challenges & Risks of Gandotinib
Table 60. Key Industry Trends of Gandotinib
Table 61. Gandotinib Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Gandotinib Distributors List
Table 64. Gandotinib Customer List
Table 65. Global Gandotinib Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Gandotinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Gandotinib Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Gandotinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Gandotinib Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Gandotinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Gandotinib Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Gandotinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Gandotinib Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Gandotinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Gandotinib Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Gandotinib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Gandotinib Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Gandotinib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. BioVision Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 80. BioVision Gandotinib Product Portfolios and Specifications
Table 81. BioVision Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 82. BioVision Main Business
Table 83. BioVision Latest Developments
Table 84. Selleck Chemicals Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 85. Selleck Chemicals Gandotinib Product Portfolios and Specifications
Table 86. Selleck Chemicals Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 87. Selleck Chemicals Main Business
Table 88. Selleck Chemicals Latest Developments
Table 89. BOC Sciences Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 90. BOC Sciences Gandotinib Product Portfolios and Specifications
Table 91. BOC Sciences Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 92. BOC Sciences Main Business
Table 93. BOC Sciences Latest Developments
Table 94. TargetMol Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 95. TargetMol Gandotinib Product Portfolios and Specifications
Table 96. TargetMol Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 97. TargetMol Main Business
Table 98. TargetMol Latest Developments
Table 99. MyBiosource Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 100. MyBiosource Gandotinib Product Portfolios and Specifications
Table 101. MyBiosource Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 102. MyBiosource Main Business
Table 103. MyBiosource Latest Developments
Table 104. Adooq Bioscience Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 105. Adooq Bioscience Gandotinib Product Portfolios and Specifications
Table 106. Adooq Bioscience Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 107. Adooq Bioscience Main Business
Table 108. Adooq Bioscience Latest Developments
Table 109. Toronto Research Chemicals Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 110. Toronto Research Chemicals Gandotinib Product Portfolios and Specifications
Table 111. Toronto Research Chemicals Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 112. Toronto Research Chemicals Main Business
Table 113. Toronto Research Chemicals Latest Developments
Table 114. AbMole Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 115. AbMole Gandotinib Product Portfolios and Specifications
Table 116. AbMole Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 117. AbMole Main Business
Table 118. AbMole Latest Developments
Table 119. Taiclone Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 120. Taiclone Gandotinib Product Portfolios and Specifications
Table 121. Taiclone Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 122. Taiclone Main Business
Table 123. Taiclone Latest Developments
Table 124. Axon Medchem Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 125. Axon Medchem Gandotinib Product Portfolios and Specifications
Table 126. Axon Medchem Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 127. Axon Medchem Main Business
Table 128. Axon Medchem Latest Developments
Table 129. CSNpharm Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 130. CSNpharm Gandotinib Product Portfolios and Specifications
Table 131. CSNpharm Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 132. CSNpharm Main Business
Table 133. CSNpharm Latest Developments
Table 134. AA BLOCKS Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 135. AA BLOCKS Gandotinib Product Portfolios and Specifications
Table 136. AA BLOCKS Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 137. AA BLOCKS Main Business
Table 138. AA BLOCKS Latest Developments
Table 139. MedKoo Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 140. MedKoo Gandotinib Product Portfolios and Specifications
Table 141. MedKoo Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 142. MedKoo Main Business
Table 143. MedKoo Latest Developments
Table 144. Wuhan Sun-Shine Bio-Technology Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 145. Wuhan Sun-Shine Bio-Technology Gandotinib Product Portfolios and Specifications
Table 146. Wuhan Sun-Shine Bio-Technology Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 147. Wuhan Sun-Shine Bio-Technology Main Business
Table 148. Wuhan Sun-Shine Bio-Technology Latest Developments
Table 149. Biosynth Carbosynth Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 150. Biosynth Carbosynth Gandotinib Product Portfolios and Specifications
Table 151. Biosynth Carbosynth Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 152. Biosynth Carbosynth Main Business
Table 153. Biosynth Carbosynth Latest Developments
Table 154. Biorbyt Basic Information, Gandotinib Manufacturing Base, Sales Area and Its Competitors
Table 155. Biorbyt Gandotinib Product Portfolios and Specifications
Table 156. Biorbyt Gandotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 157. Biorbyt Main Business
Table 158. Biorbyt Latest Developments
List of Figures
Figure 1. Picture of Gandotinib
Figure 2. Gandotinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gandotinib Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Gandotinib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gandotinib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Gandotinib Sales Market Share by Type in 2022
Figure 13. Global Gandotinib Revenue Market Share by Type (2018-2023)
Figure 14. Gandotinib Consumed in Research
Figure 15. Global Gandotinib Market: Research (2018-2023) & (Kg)
Figure 16. Gandotinib Consumed in Medical
Figure 17. Global Gandotinib Market: Medical (2018-2023) & (Kg)
Figure 18. Global Gandotinib Sales Market Share by Application (2022)
Figure 19. Global Gandotinib Revenue Market Share by Application in 2022
Figure 20. Gandotinib Sales Market by Company in 2022 (Kg)
Figure 21. Global Gandotinib Sales Market Share by Company in 2022
Figure 22. Gandotinib Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Gandotinib Revenue Market Share by Company in 2022
Figure 24. Global Gandotinib Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Gandotinib Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Gandotinib Sales 2018-2023 (Kg)
Figure 27. Americas Gandotinib Revenue 2018-2023 ($ Millions)
Figure 28. APAC Gandotinib Sales 2018-2023 (Kg)
Figure 29. APAC Gandotinib Revenue 2018-2023 ($ Millions)
Figure 30. Europe Gandotinib Sales 2018-2023 (Kg)
Figure 31. Europe Gandotinib Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Gandotinib Sales 2018-2023 (Kg)
Figure 33. Middle East & Africa Gandotinib Revenue 2018-2023 ($ Millions)
Figure 34. Americas Gandotinib Sales Market Share by Country in 2022
Figure 35. Americas Gandotinib Revenue Market Share by Country in 2022
Figure 36. Americas Gandotinib Sales Market Share by Type (2018-2023)
Figure 37. Americas Gandotinib Sales Market Share by Application (2018-2023)
Figure 38. United States Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Gandotinib Sales Market Share by Region in 2022
Figure 43. APAC Gandotinib Revenue Market Share by Regions in 2022
Figure 44. APAC Gandotinib Sales Market Share by Type (2018-2023)
Figure 45. APAC Gandotinib Sales Market Share by Application (2018-2023)
Figure 46. China Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Gandotinib Sales Market Share by Country in 2022
Figure 54. Europe Gandotinib Revenue Market Share by Country in 2022
Figure 55. Europe Gandotinib Sales Market Share by Type (2018-2023)
Figure 56. Europe Gandotinib Sales Market Share by Application (2018-2023)
Figure 57. Germany Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Gandotinib Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Gandotinib Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Gandotinib Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Gandotinib Sales Market Share by Application (2018-2023)
Figure 66. Egypt Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Gandotinib Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Gandotinib in 2022
Figure 72. Manufacturing Process Analysis of Gandotinib
Figure 73. Industry Chain Structure of Gandotinib
Figure 74. Channels of Distribution
Figure 75. Global Gandotinib Sales Market Forecast by Region (2024-2029)
Figure 76. Global Gandotinib Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Gandotinib Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Gandotinib Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Gandotinib Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Gandotinib Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のガンドチニブ市場予測 2023年-2029年(Global Gandotinib Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆